North Korea Appears Nearly Done Building Big Missile Structure

North Korea's Unha 3 space rocket lifts off in December 2012, in an image released by official state media. Recent satellite images of the country's Dochang-ri missile site indicate work is almost finished on a tower big enough to handle rockets larger than the one Pyongyang successfully launched into space more than a year ago.
National Journal
Rachel Oswald
Feb. 6, 2014, 9:52 a.m.

North Korea ap­pears to be al­most done build­ing a launch tower tall enough to handle fir­ing rock­ets even lar­ger than one suc­cess­fully launched in 2012.

The con­struc­tion pro­gress could have im­plic­a­tions for the isol­ated na­tion’s abil­ity to test po­ten­tial long-range mis­siles cap­able of car­ry­ing nuc­le­ar pay­loads, though North Korea is not known to have mastered the tech­no­logy to do so.

“Re­cent com­mer­cial satel­lite im­agery in­dic­ates that North Korea is near­ing com­ple­tion of modi­fic­a­tions to the gantry at the launch pad of the So­hae Satel­lite Launch­ing Sta­tion,” said im­age ex­pert Nick Hansen in a Thursday ana­lys­is pos­ted on the spe­cial­ist web­site “38 North.” So­hae is also known as the Dongchang-ri mis­sile launch com­plex.

An 11th level can now be seen in the im­ages, which gives the tower enough height to al­low fir­ing rock­ets as tall as 50 meters, which would be nearly 70 per­cent longer than the space rock­et North Korea suc­cess­fully launched in Decem­ber 2012, ac­cord­ing to Hansen.

He pro­jec­ted the al­ter­a­tions to the Dongchang-ri launch plat­form could be wrapped up next month or in April if con­struc­tion con­tin­ues apace.

“The pad will then be avail­able for ad­di­tion­al launches, prob­ably of the Unha 3 rock­et or a slightly longer vari­ant, such as the Unha 9, which was first dis­played as a mod­el in 2012,” he wrote.

While North Korea claims its past launches of the Unha 3 space vehicle have been peace­ful, much of the world views them as a likely cov­er for tests of in­ter­con­tin­ent­al bal­list­ic mis­siles.

What We're Following See More »
Clinton to Receive Classified Briefing on Saturday
16 minutes ago
Judge: Freddie Mac Doesn’t Have to Open Its Books
1 hours ago

"Freddie Mac shareholders cannot force the mortgage finance company to allow them to inspect its records, a federal court ruled Tuesday." A shareholder had asked the United States District Court for the Eastern District of Virginia to allow him to inspect its books and records, as Virginia law allows him to do. "The court held that Freddie shareholders no longer possess a right to inspect the company’s records because those rights had been transferred to the Federal Housing Finance Agency when the company entered into conservatorship in 2008."

Pentagon Can’t Account for 750k Guns Provided to Iraq, Afghanistan
2 hours ago

The Pentagon has "provided more than 1.45 million firearms to various security forces in Afghanistan and Iraq, including more than 978,000 assault rifles, 266,000 pistols and almost 112,000 machine guns." Trouble is, it can only account for about 700,000 of those guns. The rest are part of a vast arms trading network in the Middle East. "Taken together, the weapons were part of a vast and sometimes minimally supervised flow of arms from a superpower to armies and militias often compromised by poor training, desertion, corruption and patterns of human rights abuses."

Baltimore Is Spying on Its Residents from the Air
4 hours ago

"Since the beginning of the year, the Baltimore Police Department" has been using a Cessna airplane armed with sophisticated camera equipment "to investigate all sorts of crimes, from property thefts to shootings." The public hasn't been notified about the system, funded by a private citizen.

EpiPen Prices Draw Scrutiny from Congress
5 hours ago

The cost of EpiPens have risen 400% since 2007, and members of Congress increasingly want to know why. Judiciary Chairman Charles Grassley (R-IA) sent a letter to Mylan, which makes the allergy injection devices, on Monday. “Many of the children who are prescribed EpiPens are covered by Medicaid, and therefore, the taxpayers are picking up the tab for this medication," he wrote. Sen. Amy Klobuchar (D-MN) "called earlier for a Judiciary Committee inquiry into the pricing and an investigation by the Federal Trade Commission."